Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

GP100 expression is variable in intensity in melanoma

Cancer Immunology Immunotherapy(2024)10.1007/s00262-024-03776-5Source: DataRank Database

GP100 expression is variable in intensity in melanoma is a research paper published in Cancer Immunology Immunotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (29)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Nitzan Hasson,David Su ORCID,Adebowale Adeniran ORCID,Keiran S.M. Smalley ORCID,Dijana Djureinovic ORCID

Live enrichment

PubMed:39105816 PMC:PMC11303354

NIH

Grant: 1T32AI155387-01A1

Human and Translational Immunology Training Program

NIH

Grant: 1R01CA269349

NCI NIH HHS

Grant: R01 CA269349

NIAID NIH HHS

Grant: T32 AI155387

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 5R01CA269349-03

Dual-isotope SPECT imaging and immunophenotyping of immune cells to determine response to immunotherapy

National Institutes of Health

Grant: 2P50CA121974-06A1

The RAC1 Pathway as aTarget for Melanoma Therapy

National Institutes of Health

Grant: 5R01CA269286-02

Immune Therapy for Brain Metastasis

goldLicense: cc-by

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-024-03776-5.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-024-03776-5/fulltext.html

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11303354/pdf/262_2024_Article_3776.pdf

Unpaywallhttps://doi.org/10.1007/s00262-024-03776-5

Europe_PMChttps://europepmc.org/articles/PMC11303354

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansMelanomaSkin NeoplasmsImmunohistochemistryAgedMiddle AgedFemaleMalegp100 Melanoma AntigenBiomarkers, TumorCutaneous Malignant Melanoma

Keywords

MelanomaTargeted TherapyImmtacGlycoprotein 100TebentafuspMaleSkin NeoplasmsBrief ReportMiddle AgedImmunohistochemistryCutaneous Malignant MelanomaBiomarkers, TumorHumansFemalegp100 Melanoma AntigenAged

GP100 expression is variable in intensity in melanoma

FAIR Checklist

Authors (9)

Funding (8 grants)

Open Access

Topics

Annotations (Europe PMC)